The Einstein Medical Center Philadelphia is a non-profit hospital located in Philadelphia, Pennsylvania. The hospital is a part of the Einstein Healthcare Network. The medical center offers residency and fellowship training programs in many specialized areas.

There are 701 beds in Albert Einstein Healthcare Network.

During the past decade, Albert Einstein Healthcare Network conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 12 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albert Einstein Healthcare Network" #1 sponsor was "Albert Einstein Healthcare Network" with 14 trials, followed by "NSABP Foundation Inc" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Intercept Pharmaceuticals" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albert Einstein Healthcare Network" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Albert Einstein Healthcare Network" with 1 trials as a collaborator, "Aramark Healthcare" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Albert Einstein Healthcare Network" are "Breast Cancer" (4 trials), "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Peripheral Arterial Disease" (2 trials) and "Acute Kidney Disease" (1 trials). Many other conditions were trialed in "Albert Einstein Healthcare Network" in a lesser frequency.

Most popular intervention types in "Albert Einstein Healthcare Network" are "Drug" (21 trials), "Device" (10 trials), "Other" (6 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (2 trials), "Bevacizumab" (2 trials), "Cyclophosphamide" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Albert Einstein Healthcare Network" are 33 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Albert Einstein Healthcare Network". 1 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Albert Einstein Healthcare Network, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Albert Einstein Healthcare Network, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 16 trials that are defined as “Not Applicable".

Albert Einstein Healthcare Network has several departments that took part in Clinical trials: "Albert Einstein Medical Center; Division of Hepatology" - 2 trials